BFM
TYRA icon

Boothbay Fund Management’s Tyra Biosciences TYRA Stock Holding History

Boothbay Fund Management’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.5M Buy
273,274
+52,097
+24% +$1.69M 0.14% 124
2025
Q4 		$5.81M Buy
221,177
+34,507
+18% +$634K 0.09% 253
2025
Q3 		$2.61M Buy
+186,670
New +$2.13M 0.04% 506
2025
Q1 		– Sell
-17,560
Closed -$244K – 1799
2024
Q4 		$244K Buy
+17,560
New +$319K 0.01% 1139
2023
Q3 		– Sell
-10,174
Closed -$173K – 2090
2023
Q2 		$173K Buy
+10,174
New +$148K ﹤0.01% 1512

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $151M AUM 296.21% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Boothbay Fund Management's TYRA Position: Q1 2026 in Review

Boothbay Fund Management increased its Tyra Biosciences (TYRA) stake by 24% in Q1 2026, buying an estimated $1.69M and bringing the position to 273,274 shares worth $10.5M. The position accounts for 0.14% of the portfolio, ranked #124.

Boothbay Fund Management first reported a position in TYRA in Q2 2023 and has held it in 5 quarters since. 164 funds tracked by Wall St. Rank hold TYRA as of Q1 2026.

  • Boothbay Fund Management held 273,274 shares of Tyra Biosciences worth $10.5M as of Q1 2026.
  • Boothbay Fund Management bought 52,097 Tyra Biosciences shares in Q1 2026, an estimated $1.69M.
  • Tyra Biosciences made up 0.14% of Boothbay Fund Management's portfolio in Q1 2026, its #124 holding.
  • Boothbay Fund Management first reported a position in Tyra Biosciences in Q2 2023 and has held it in 5 quarters since.
  • 164 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.